Table 3.
Endogenous | Dosed therapeutic (hypothetical) | |||
---|---|---|---|---|
Parameter | Mean value | Ref | Mean value | Ref |
IgG serum concentration | 11.8 mg/mL | ref.31 | 0.1 mg/mL* | n/a |
%IgG2 | 22% | ref.25 | 100% | n/a |
%IgG2-A (of IgG2) | 7.2% | ref.19 | 25% | n/a |
%2Cys (of IgG2-A) | 0.8% | This study | 0.5% | n/a |
Doubly cysteinylated IgG2-A exposure in serum | 1.5 µg/mL | 0.125 µg/mL |
*Assuming a hypothetical IgG2 therapeutic dose of 250 mg and an average human serum volume of 2.5L.